Drugs
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 10/26/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today issued a statement on the Company's use of specialty phar ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/22/15 -- Two British Columbia-headquartered biotech organizations are expanding their successful collaboration to develop much needed treatments fo ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/22/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 10/22/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the Company will release its financial results for the third quarter 2015 on Thursday, Novembe ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 10/21/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and comm ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/20/15 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the quarter ended September 30, 2015 after market cl ...
MONCTON, NEW BRUNSWICK: MONCTON, NEW BRUNSWICK -- (Marketwired) -- 10/16/15 -- OrganiGram Holdings Inc. (TSX VENTURE: OGI)(OTCQX: OGRMF) (the "Company") announces the granting of 574,165 stock options at an exerc ...
ANN ARBOR, MI: Renowned Retinal Disease Thought Leaders to Help Guide Development of Novel Vision Protection Technology in Age-Related Macular Degeneration (AMD) and Retinal Detachment ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/13/15 -- A new type of cancer therapy based on seemingly unrelated elements of malaria and cancer is showing promise for development. Kairos Therap ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/07/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/05/15 -- Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical ...
LEAMINGTON, ONTARIO: Quarterly revenue increase of 90% with registered patients more than doubling ...
SHANGHAI, CHINA and BOTHELL, WA: SHANGHAI, CHINA and BOTHELL, WA -- (Marketwired) -- 09/28/15 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases and Ho ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/28/15 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries, ("Knight") announced today that it has entered into an e ...
SOUTH SAN FRANCISCO, CA: Agency Action Expected by Feb. 27, 2016 on Probuphine for Maintenance Treatment of Opioid Dependence ...
LONDON, UNITED KINGDOM: LONDON, UNITED KINGDOM -- (Marketwired) -- 09/27/15 -- GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced data presented by GSK at the European Respiratory Society (ERS) In ...
PHOENIX, AZ: Partnership Enhances the Position of Insys as Potential Leader in Synthetic Pharmaceutical Cannabinoids ...
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA: LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/24/15 -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the intention to file a s ...
